15 reports

  • STATINS
  • INCREASING USE OF STATINS

You can easily book an appointment with one online.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • Clinical Trial profile. 160 Trial Title
  • Official Title

ET Real world treatment patterns Patient Perspectives on Cholesterol Lowering Therapies Among Those Who Report Statin-associated Adverse Events.

  • Cardiovascular Disease
  • Clinical Trial
  • Drug Development
  • Statins
  • World
  • Clinical Trial profile. 210 Trial Title
  • Clinical Trial profile. 169 Trial Title

ET Real world treatment patterns Patient Perspectives on Cholesterol Lowering Therapies Among Those Who Report Statin-associated Adverse Events.

  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • Therapy
  • World
  • Mar 13, 2019: New cholesterol-lowering drug could help patients unable to take statins
  • BEMPEDOIC ACID - DRUG PROFILE

Among the completed Phase III trials, in study ## (patients with ASCVD on MTD statin), bempedoic acid ##mg lowered LDL-C by ## percent.

  • Chronic Disease
  • Statins
  • United States
  • Company
  • Amarin Corporation plc
  • STATINS
  • STATINS

The prevalence rate for FH ranges between one in ## to one in ## people.

  • Statins
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Target
  • Clinical Trial profile. 513 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World

Part ##.

  • Clinical Trial
  • Drug Development
  • Statins
  • World
  • Merck & Co., Inc.
  • Official Title

Part ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • World
  • Merck & Co., Inc.
  • Target
  • Target

The prominent features of this report are - ##.

  • Clinical Trial
  • Lipid Modifying Drug
  • Pharmaceutical
  • Statins
  • World
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns
  • May 03, 2013: Merck Gets FDA Approval For Liptruzeta For Treatment Of Primary Or Mixed Hyperlipidemia

Liptruzet contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one of the most widely prescribed statins in the US.

  • Lipid Modifying Drug
  • Statins
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns
  • May 03, 2013: Merck Gets FDA Approval For Liptruzeta For Treatment Of Primary Or Mixed Hyperlipidemia

Niemann Pick C## Like Protein ## (NPC##L##) - Dormant Projects When using ZETIA with a statin, also follow the label recommendations for that specific statin.

  • Lipid Modifying Drug
  • Statins
  • United States
  • World
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Statins
  • World
  • Product Initiative
  • Target
  • Official Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • Mar 18, 2017: No Benefit of Synthetic HDL-C on Arterial Plaque
  • ATHEROSCLEROSIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017*

In the E. U., Praluent is approved for the treatment of adult patients with primary hypercholesterolemia (HeFH and non-familial) or mixed dyslipidemia as an adjunct to diet: a) in combination with a statin, or statin with other lipid-lowering therapies in patients unable to reach th

  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • Statins
  • World
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • most common adverse events (AEs) in this trial were nasopharyngitis, injection-site reaction and headache.

One arm of the study will focus on evaluating the effect of CAT-2003 on lipid levels in combination with statins in patients with hypercholesterolemia.

  • Endocrine Disease
  • Statins
  • United States
  • Company
  • Product Initiative